Please ensure Javascript is enabled for purposes of website accessibility Contrarian Fund - Janus Henderson Investors - US Investor
For Individual Investors in the US

Contrarian Fund Holdings

Full Portfolio Holdings

(As of January 31, 2026)

% OF INVESTMENTS
Oracle Corp 6.43
Amazon.com Inc 6.09
Capital One Financial Corp 5.46
PNC Financial Services Group Inc 5.34
Taiwan Semiconductor Manufacturing Co Ltd (ADR) 5.25
Vertiv Holdings Co 5.13
Surgery Partners Inc 4.25
Nebius Group NV 3.70
Howmet Aerospace Inc 3.51
Caesars Entertainment Inc 2.92
UnitedHealth Group Inc 2.89
Flutter Entertainment PLC 2.86
Blackstone Inc 2.81
Nexstar Media Group Inc 2.80
Hong Kong Exchanges & Clearing Ltd 2.72
Argenx SE (ADR) 2.67
3M Co 2.66
Intercontinental Exchange Inc 2.63
Western Alliance Bancorp 2.60
Marvell Technology Inc 2.32
Madrigal Pharmaceuticals Inc 2.07
Cullen/Frost Bankers Inc 2.02
Builders FirstSource Inc 1.71
Sotera Health Co 1.68
Lumentum Holdings Inc 1.58
Wingstop Inc 1.55
Core & Main Inc 1.48
Cipher Mining Inc 1.40
Baker Hughes Co 1.34
Medline Inc 1.19
Legence Corp 1.17
Datadog Inc 0.96
Sportradar Group AG 0.91
Workday Inc 0.84
Vaxcyte Inc 0.79
Structure Therapeutics Inc (ADR) 0.75
Bullish 0.69
Mid-America Apartment Communities Inc 0.65
Glaukos Corp 0.58
Lantheus Holdings Inc 0.55
PFIZER INC 0.03
AMZN US 20Feb26 Put (AMERICAN PHYSICAL) BAML OTC 220 -0.01
ORCL US 20Feb26 Put (AMERICAN PHYSICAL) GS OTC 160 -0.01
VRT US 20Feb26 Call (AMERICAN PHYSICAL) MS OTC 220 -0.02
UNH US 20Feb26 Put (AMERICAN PHYSICAL) BAML OTC 360 -0.16
Cash & Equivalents 1.22
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.